We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9,
Telephone: +353 1 295 9620
Fax: : +353 1 816 3642
Medical Information e-mail: Medinfo@dbl.boehringer-ingelheim.com
Patient Information Leaflet last updated on medicines.ie: 01/12/2017
PIL APTIVUS 100 mg/ml oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 01/12/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 6 - date of revision
Updated on 09/08/2017 and displayed until 01/12/2017
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
  • Change to other sources of information section
Updated on 20/04/2016 and displayed until 09/08/2017
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 21/09/2015 and displayed until 20/04/2016
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 03/07/2015 and displayed until 21/09/2015
Reasons for adding or updating:
  • Change to packaging
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to how the medicine works
  • Change to date of revision
  • Change to dosage and administration
Updated on 02/10/2014 and displayed until 03/07/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Addition of information on reporting a side effect.
Updated on 11/08/2014 and displayed until 02/10/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 22/04/2014 and displayed until 11/08/2014
Reasons for adding or updating:
  • Change to side-effects
  • Addition of information on reporting a side effect.
Updated on 27/01/2014 and displayed until 22/04/2014
Reasons for adding or updating:
  • Change to drug interactions
  • Change to MA holder contact details
Updated on 24/06/2013 and displayed until 27/01/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 30/04/2013 and displayed until 24/06/2013
Reasons for adding or updating:
  • Change to drug interactions
  • Correction of spelling/typing errors
Updated on 21/08/2012 and displayed until 30/04/2013
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 03/10/2011 and displayed until 21/08/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to drug interactions
  • Change to date of revision
Updated on 10/11/2010 and displayed until 03/10/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to dosage and administration
Updated on 26/02/2010 and displayed until 10/11/2010
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Tipranavir